The Clorox Company $CLX Stock Holdings Increased by Citizens Financial Group Inc. RI

Key Points

• Citizens Financial Group increased its Clorox position by 346% in the third quarter, bringing its holdings to 24,187 shares valued at approximately $1.96 million. Institutional investors collectively own 78.53% of Clorox.
• Clorox reported quarterly EPS of $1.66, ahead of estimates, while revenue reached $1.95 billion but declined 2% year over year. The company declared a $1.25 quarterly dividend, representing a 5.8% annualized yield.
• Analyst sentiment remains cautious: Clorox has an average “Reduce” rating and a consensus price target of $93.57, compared with shares trading at $86.78.

Citizens Financial Group Inc. RI raised its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 346.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,187 shares of the company's stock after purchasing an additional 18,764 shares during the period. Citizens Financial Group Inc. RI's holdings in Clorox were worth $1,959,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. BlackRock Inc. acquired a new position in shares of Clorox in the 2nd quarter valued at about $958,640,000. Bank of America Corp DE bought a new stake in Clorox in the second quarter valued at about $179,780,000. Royal Bank of Canada increased its holdings in shares of Clorox by 20.1% in the first quarter. Royal Bank of Canada now owns 1,418,204 shares of the company's stock worth $146,969,000 after acquiring an additional 237,301 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Clorox by 2.3% in the 1st quarter. Bank of New York Mellon Corp now owns 1,280,226 shares of the company's stock worth $132,670,000 after purchasing an additional 29,181 shares during the period. Finally, Confluence Investment Management LLC raised its holdings in shares of Clorox by 33.8% in the second quarter. Confluence Investment Management LLC now owns 1,247,644 shares of the company's stock valued at $119,075,000 after purchasing an additional 315,069 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Trading Up 0.4%

Shares of Clorox stock opened at $86.78 on Tuesday. The Clorox Company has a 1-year low of $79.12 and a 1-year high of $128.90. The company's fifty day simple moving average is $90.49 and its 200-day simple moving average is $100.42. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38. The stock has a market capitalization of $10.50 billion, a PE ratio of 18.00, a P/E/G ratio of 2.89 and a beta of 0.59.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.91 billion. During the same quarter in the previous year, the company posted $2.87 earnings per share. Clorox's revenue for the quarter was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities analysts anticipate that The Clorox Company will post 5.66 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 5.8%. The ex-dividend date is Wednesday, October 28th. Clorox's dividend payout ratio is presently 103.73%.

Analyst Ratings Changes

CLX has been the topic of several research analyst reports. Zacks Research raised shares of Clorox from a "strong sell" rating to a "hold" rating in a report on Monday, September 14th. UBS Group set a $91.00 price target on shares of Clorox in a report on Thursday, October 15th. Citigroup dropped their target price on Clorox from $97.00 to $90.00 and set a "neutral" rating on the stock in a research report on Wednesday, October 14th. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $95.00 to $83.00 and set an "underweight" rating on the stock in a report on Monday, October 19th. Finally, Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a $95.00 price objective on shares of Clorox in a research report on Monday, October 19th. Twelve analysts have rated the stock with a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, Clorox currently has an average rating of "Reduce" and a consensus price target of $93.57.

About Clorox

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.